NEW YORK CITY (dpa-AFX) - Bangladesh-based Beximco Pharmaceuticals Limited has launched Bexovid, a generic version of Pfizer Inc.'s (PFE) COVID-19 treatment Paxlovid.Paxlovid, which consists of
Beximco Pharmaceuticals Limited, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today (Thursday) announced the launch of the world's first generic version of Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged…